The clinical presentation and outcomes of COVID-19 in immunocompromised hosts in comparison to comorbid and immunocompetent patients: retrospective study of 384 cases

Basit Öğe Kaydı
dc.contributor.authorKarimov, Ziya
dc.contributor.authorHuseynova, Gunay
dc.contributor.authorKırıs, Hakan Turan
dc.contributor.authorTongel, Cansu
dc.contributor.authorAlıyeva, Aynur
dc.contributor.authorSoyer, Nur
dc.contributor.authorAbdullayeva, Nigar
dc.date.accessioned2024-08-31T07:31:18Z
dc.date.available2024-08-31T07:31:18Z
dc.date.issued2024
dc.departmentEge Üniversitesien_US
dc.description.abstractAim: Immunocompromised hosts (ICH) are at a higher risk of severe infections and mortality. This study aimed to examine the clinical manifestations and outcomes of ICH who were admitted to the hospital for COVID-19. Materials and Methods: A total of 384 patients (mean age 61.5?15.9 y, 168 female) who were hospitalized between March 2020 and December 2020 were included in the study. These patients were examined in three groups: the ICH (n=40), comorbid patients (n=101), and the control group comprising immunocompetent patients without any comorbidities (n=243). All clinical and laboratory data were retrieved from the electronic hospital records and compared between the three groups retrospectively. Results: The mean age was 61.2?15.0 for ICH, 66.1?12.3 for comorbid, and 59.6?17.0 for control groups (p=0.003). We found that the mean leukocyte and neutrophil counts, C-reactive protein (CRP), ferritin, and D-Dimer levels were significantly higher, and the albumin level was lower in ICH compared to the other two groups (p<0.05). On CT scans, ground-glass opacities were seen less frequently in ICH compared to the other groups (p=0.035). The mortality rate was 32.5% in the ICH, 22.8% in the comorbid, and 15.2% in the control groups (p=0.019). Within the ICH group, the mean leukocyte, and neutrophil counts and LDH levels were higher and the SpO2/FiO? ratio was lower in patients who died (p<0.05). Conclusion: We found that had higher mortality in ICH with COVID-19. Being ICH condition, elder age, elevated LDH levels, and decreased Sat/FiO2 were associated with increased mortality.en_US
dc.identifier.doi10.19161/etd.1256543
dc.identifier.endpage198en_US
dc.identifier.issn1016-9113
dc.identifier.issn2147-6500
dc.identifier.issue2en_US
dc.identifier.startpage192en_US
dc.identifier.trdizinid1240584en_US
dc.identifier.urihttps://doi.org/10.19161/etd.1256543
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1240584
dc.identifier.urihttps://hdl.handle.net/11454/103403
dc.identifier.volume63en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofEge Tıp Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240831_Uen_US
dc.subjectClinical outcomesen_US
dc.subjectCOVID-19en_US
dc.subjectimmunocompromiseden_US
dc.subjectimmunosuppresseden_US
dc.subjectpandemicen_US
dc.titleThe clinical presentation and outcomes of COVID-19 in immunocompromised hosts in comparison to comorbid and immunocompetent patients: retrospective study of 384 casesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu